HK1170673A1 - Compositions and methods for increasing blood platelet levels in humans - Google Patents

Compositions and methods for increasing blood platelet levels in humans

Info

Publication number
HK1170673A1
HK1170673A1 HK12111489.1A HK12111489A HK1170673A1 HK 1170673 A1 HK1170673 A1 HK 1170673A1 HK 12111489 A HK12111489 A HK 12111489A HK 1170673 A1 HK1170673 A1 HK 1170673A1
Authority
HK
Hong Kong
Prior art keywords
humans
compositions
methods
blood platelet
increasing blood
Prior art date
Application number
HK12111489.1A
Other languages
English (en)
Inventor
Robert E Desjardins
Rudolph Lucek
Original Assignee
Akarx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akarx Inc filed Critical Akarx Inc
Publication of HK1170673A1 publication Critical patent/HK1170673A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
HK12111489.1A 2006-08-08 2012-11-13 Compositions and methods for increasing blood platelet levels in humans HK1170673A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US83633406P 2006-08-08 2006-08-08

Publications (1)

Publication Number Publication Date
HK1170673A1 true HK1170673A1 (en) 2013-03-08

Family

ID=39082656

Family Applications (1)

Application Number Title Priority Date Filing Date
HK12111489.1A HK1170673A1 (en) 2006-08-08 2012-11-13 Compositions and methods for increasing blood platelet levels in humans

Country Status (9)

Country Link
US (2) US20080039475A1 (fr)
EP (2) EP2056826B1 (fr)
JP (3) JP2010500361A (fr)
AU (2) AU2007284644B2 (fr)
CA (1) CA2660283C (fr)
ES (2) ES2470333T3 (fr)
HK (1) HK1170673A1 (fr)
IL (4) IL196897A (fr)
WO (1) WO2008021283A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2416304T3 (es) 2002-01-18 2013-07-31 Astellas Pharma Inc. Derivado de 2-acilaminotiazol o sal del mismo
JP2013501811A (ja) * 2009-08-14 2013-01-17 エーザイ インコーポレーテッド 血小板産生を刺激するためのｅ５５０１の使用
CN112022825B (zh) * 2020-08-24 2024-03-22 瑞阳制药股份有限公司 马来酸阿伐曲泊帕片剂及其制备方法

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5330998A (en) * 1988-03-08 1994-07-19 Pfizer Inc. Thiazolidinedione derivatives as hypoglycemic agents
US5256675A (en) * 1989-08-07 1993-10-26 Fujisawa Pharmaceutical Co., Ltd. Thiazole derivatives, processes for production thereof and pharmaceutical compositions comprising the same
IE68593B1 (en) * 1989-12-06 1996-06-26 Sanofi Sa Heterocyclic substituted acylaminothiazoles their preparation and pharmaceutical compositions containing them
FR2677356B1 (fr) * 1991-06-05 1995-03-17 Sanofi Sa Derives heterocycliques d'acylamino-2 thiazoles-5 substitues, leur preparation et compositions pharmaceutiques en contenant.
US5250732A (en) * 1991-07-18 1993-10-05 Genentech, Inc. Ketamine analogues for treatment of thrombocytopenia
GB9126677D0 (en) * 1991-12-16 1992-02-12 Johnson Matthey Plc Improvements in chemical compounds
EP0620403B1 (fr) * 1993-04-08 1996-12-04 ABB Management AG Dispositif de mélange et de stabilisation de la flamme dans une chambre de combustion avec mélange préalable du combustible.
DE69629341T2 (de) * 1995-03-09 2004-06-09 Kyowa Hakko Kogyo Co., Ltd. Pyrrolocarbazolderivate
KR19990008109A (ko) * 1995-04-28 1999-01-25 나가사까 겐지로 1,4-이치환 피페리딘 유도체
CN1315870C (zh) * 1995-06-07 2007-05-16 葛兰素集团有限公司 结合血小板生成素受体的肽和化合物
US5963666A (en) * 1995-08-18 1999-10-05 International Business Machines Corporation Confusion matrix mediated word prediction
WO1997014704A1 (fr) * 1995-10-17 1997-04-24 Suntory Limited Medicament contre la thrombopenie
US5932546A (en) * 1996-10-04 1999-08-03 Glaxo Wellcome Inc. Peptides and compounds that bind to the thrombopoietin receptor
US6187797B1 (en) * 1996-12-23 2001-02-13 Dupont Pharmaceuticals Company Phenyl-isoxazoles as factor XA Inhibitors
JP2002526482A (ja) * 1998-09-18 2002-08-20 バーテックス ファーマシューティカルズ インコーポレイテッド ｐ３８のインヒビター
US6498155B1 (en) * 1998-11-17 2002-12-24 Smithkline Beecham Corporation Methods of treating thrombocytopenia
TWI284639B (en) * 2000-01-24 2007-08-01 Shionogi & Co A compound having thrombopoietin receptor agonistic effect
GB0028383D0 (en) * 2000-11-21 2001-01-03 Novartis Ag Organic compounds
WO2002062792A1 (fr) * 2001-02-02 2002-08-15 Takeda Chemical Industries, Ltd. Inhibiteur de jnk
JPWO2002062775A1 (ja) * 2001-02-02 2004-06-10 山之内製薬株式会社 ２−アシルアミノチアゾール誘導体又はその塩
ES2416304T3 (es) * 2002-01-18 2013-07-31 Astellas Pharma Inc. Derivado de 2-acilaminotiazol o sal del mismo
MXPA05000130A (es) * 2002-06-27 2005-02-17 Novo Nordisk As Derivados de aril-carbonilo como agentes terapeuticos.
AU2003268687A1 (en) * 2002-09-30 2004-04-19 Yamanouchi Pharmaceutical Co., Ltd. Novel salt of 2-acylaminothiazole derivative
AU2004225965A1 (en) * 2003-03-25 2004-10-14 Vertex Pharmaceuticals Incorporated Thiazoles useful as inhibitors of protein kinases
EP1647553A4 (fr) * 2003-07-17 2008-12-31 Astellas Pharma Inc Derive 2-acylaminothiazole ou sel de celui-ci
US7601746B2 (en) * 2003-08-12 2009-10-13 Shionogi & Co., Ltd. Compounds exhibiting thrombopoietin receptor agonism
KR20080074166A (ko) * 2005-11-08 2008-08-12 아스테라스 세이야쿠 가부시키가이샤 혈소판감소증을 치료하는 조성물 및 방법

Also Published As

Publication number Publication date
IL245911A0 (en) 2016-07-31
IL240322A0 (en) 2015-09-24
ES2452032T3 (es) 2014-03-31
JP2010500361A (ja) 2010-01-07
AU2011253775A1 (en) 2011-12-22
EP2452674A3 (fr) 2012-05-30
US20110224226A1 (en) 2011-09-15
AU2011253775B2 (en) 2014-02-13
JP2013047257A (ja) 2013-03-07
AU2007284644A1 (en) 2008-02-21
IL196897A (en) 2015-08-31
EP2056826A2 (fr) 2009-05-13
EP2452674B1 (fr) 2014-03-26
JP6258264B2 (ja) 2018-01-10
WO2008021283A3 (fr) 2008-12-11
WO2008021283A2 (fr) 2008-02-21
IL196897A0 (en) 2011-08-01
JP2015221806A (ja) 2015-12-10
EP2056826A4 (fr) 2009-09-09
EP2056826B1 (fr) 2014-01-08
ES2470333T3 (es) 2014-06-23
IL240323A0 (en) 2015-09-24
US20080039475A1 (en) 2008-02-14
EP2452674A2 (fr) 2012-05-16
CA2660283A1 (fr) 2008-02-21
CA2660283C (fr) 2014-11-18
IL240323A (en) 2016-05-31
AU2007284644B2 (en) 2011-09-01

Similar Documents

Publication Publication Date Title
IL195619A0 (en) Compositions and methods for joininig non-conjoined iumens
HK1137670A1 (en) Compositions and methods for arthrodetic procedures
EP1973986A4 (fr) Compositions bioactives complexes et leurs méthodes d'utilisation
ZA200900388B (en) Compositions and methods for the treatment of mucositis
HK1125868A1 (en) Compositions and methods for treating bone
EP2101731A4 (fr) Procédés et compositions d'endoxifène
EP2046936A4 (fr) Compositions biocides et méthodes
ZA200808431B (en) Fungicidal compositions and methods of using the same
EP2109673A4 (fr) Procedes et compositions pour l'expression et la purification de proteines ameliorees
EP2088865A4 (fr) Procédés et compositions autour de guggulphospholipides
GB0721291D0 (en) Methods and compositions
GB0617171D0 (en) Novel compositions and methods
EP2076281A4 (fr) Compositions alkylglycosidiques stabilisatrices et leurs procédés
IL196411A0 (en) Anti-cocaine compositions and treatment
PL2061458T3 (pl) Kompozycje topiramatu i sposoby ich stosowania
ZA200707490B (en) Methods and compositions for modulatiing vascular integrity
GB0719526D0 (en) Compositions and methods
EP2029132A4 (fr) Compositions antihistaminiques et leur utilisation
IL245911A0 (en) Compositions and methods for increasing the level of blood platelets in humans
HK1129596A1 (en) Methods and compositions for treating disease
PL2132251T3 (pl) Kompozycja i sposób
GB0625208D0 (en) Composition and method
GB0620695D0 (en) Composition and methods for the treatment of nurdegenerative disease
GB0718271D0 (en) Lubricant formulations and methods
GB0600261D0 (en) Composition and method